Variability of temperature during chemotherapy treatment

  • Research type

    Research Study

  • Full title

    Natural variability of body temperature in patients receiving chemotherapy

  • IRAS ID

    184703

  • Contact name

    Helen Ashdown

  • Contact email

    helen.ashdown@phc.ox.ac.uk

  • Sponsor organisation

    R&D Department, Oxford University Hospitals NHS Trust

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    0 years, 10 months, 30 days

  • Research summary

    Patients who are receiving chemotherapy can be at risk of an important condition called “febrile neutropenia” which is due to low levels of white blood cells. It can be serious and needs urgent assessment and treatment. One of the signs of this may be developing a fever (high body temperature) and so patients may be advised to monitor their temperature during chemotherapy treatment.

    We would like to understand more about how chemotherapy treatment affects how body temperature changes over the course of a chemotherapy cycle, and how it changes when someone develops febrile neutropenia. This will help us to develop advice about how best to measure temperature during chemotherapy for future patients.

    We will invite patients who are starting a chemotherapy treatment cycle at the Day Treatment Unit at the Churchill Hospital, Oxford, to take part in our study, which is an unfunded study. We will ask patients to record their temperature in a diary whenever they measure it during the chemotherapy cycle, along with the date and time. This will not involve making any extra measurements for the study, just writing down the ones taken anyway. We will also ask patients to record simple details about any unplanned visits to hospital and the reason, and record information from hospital records with details of the hospital admission.

    We will analyse this data to find out what normal body temperature variation is during chemotherapy, and will also look at temperature variations in the days leading up to any hospital admissions for neutropenic sepsis.

  • REC name

    North East - York Research Ethics Committee

  • REC reference

    15/NE/0267

  • Date of REC Opinion

    24 Jul 2015

  • REC opinion

    Favourable Opinion